Short description
Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.
Description
Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Lausanne, Vaud, Switzerland, Europe
Founded on
January 1, 2007
Exited on
April 24, 2015
Went public on
April 24, 2015
Stock symbol
BCART
Non-profit?
No
Acquired?
No
Employees count
501-1000
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Noaccessforu, Noaccess, Noaccess, No Way, Noaccess, Uh Ohhhh, Absolutely Noaccess, No Way, No Way, Absolutely Noaccess, Noway Youcantaccess, Absolutely Noaccess, Nopepepe, Uh Ohhhh, Uh Ohhhh, Blurry Noaccess, Uh Ohhhh, Noaccessforu
Sign in for full access
Founders
Nader Donzel, Rudi Pauwels
Funding rounds count
2
Portfolio organisations count
Noway Youcantaccess, No Way
Sign in for full access
Lead investments count
1